Belgium· BE-AMP-SAM100177-00
Kaliphos 1.36 g/10 ml - 1.74 g/10 ml
A kaliumphosphat, inkl. kombinationen von sonstigen kaliumsalzen product containing dipotassium hydrogen phosphate, registered in Belgium by Laboratoires Sterop. The same ATC class is registered in 7 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Kaliumphosphat, inkl. kombinationen von sonstigen kaliumsalzen is registered in 7 of 19 countries.
Countries holding a registration under ATC B05XA06 (kaliumphosphat, inkl. kombinationen von sonstigen kaliumsalzen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Kaliumphosphat, inkl. kombinationen von sonstigen kaliumsalzen · ATC B05XA06
7 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Ireland
- Norwayprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Dipotassium Hydrogen Phosphate
- Manufacturer
- Laboratoires Sterop
- Country
- Belgium (BE)
- ATC code
- B05XA06
- ATC class
- Kaliumphosphat, inkl. Kombinationen von sonstigen Kaliumsalzen
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2117521
- be_apb2117513
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
73 interactions on record for kaliumphosphat, inkl. kombinationen von sonstigen kaliumsalzen.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Kaliumphosphat, inkl. kombinationen von sonstigen kaliumsalzen · interactions on record
73 records
73 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under B05XA06
Kaliumphosphat, inkl. kombinationen von sonstigen kaliumsalzen, as other registers publish it.
- FinlandAddex-KaliumFresenius Kabi AB
- CzechiaDIHYDROGENFOSFOREČNAN DRASELNÝ ARDEAPHARMAARDEAPHARMA, a.s., Ševětín
- CzechiaDIHYDROGENFOSFOREČNAN DRASELNÝ ARDEAPHARMAARDEAPHARMA, a.s., Ševětín
- CzechiaDIHYDROGENFOSFOREČNAN DRASELNÝ ARDEAPHARMAARDEAPHARMA, a.s., Ševětín
- CzechiaDIHYDROGENFOSFOREČNAN DRASELNÝ ARDEAPHARMAARDEAPHARMA, a.s., Ševětín
- NorwayFosfato Monopotassico braunB. Braun Medical
- FinlandK-FosfosterilOrion Corporation Orion Pharma
- FinlandK-KonsentraattiOrion Corporation Orion Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c568ac89-5da1-4906-bd57-636dc5ce0726 GET /v1/drugs/c568ac89-5da1-4906-bd57-636dc5ce0726?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Kaliphos 1.36 g/10 ml - 1.74 g/10 ml",
"name_fr": "Kaliphos 1.36 g/10 ml - 1.74 g/10 ml",
"name_nl": "Kaliphos 1.36 g/10 ml - 1.74 g/10 ml",
"amp_code": "SAM100177-00",
"strengths": [
"1.7400",
"1.3600"
],
"pack_count": 2,
"substances": [
"Dipotassium Hydrogen Phosphate",
"Potassium Dihydrogen Phosphate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Potassium Phosphate, Incl. Combinations with Other Potassium Salts",
"authorisation_numbers": [
"BE100177"
]
}See everything about kaliumphosphat, inkl. kombinationen von sonstigen kaliumsalzen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.